Although previous reports indicated that FTI-treatment enhances the expression of RhoB in gastric cancer [35] or breast cancer [36] cells, in the present study, FTI-treatment did not enhance the expression of RhoB in BHP18-21v, FRO, or WRO cells. Here, RHOB is linked to breast cancer.